Jos Jansen

128 Chapter 5 33. Stewart SH, Reuben A, Anton RF. Relationship of Abnormal Chromatographic Pattern for Carbohydrate-Deficient Transferrin with Severe Liver Disease. Alcohol and alcoholism. 2017;52(1):24-8. 34. Mann AC, Record CO, Self CH, Turner GA. Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clinica chimica acta; international journal of clinical chemistry. 1994;227(1-2):69-78. 35. Zhu J, Lin Z, Wu J, Yin H, Dai J, Feng Z, et al. Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies. Journal of proteome research. 2014;13(6):2986-97. 36. Vanderschaeghe D, Laroy W, Sablon E, Halfon P, Van Hecke A, Delanghe J, et al. GlycoFibroTest is a highly performant liver fibrosis biomarker derived from DNA sequencer-based serum protein glycomics. Molecular & cellular proteomics : MCP. 2009;8(5):986-94. 37. 37. Bruns T, Nuraldeen R, Mai M, Stengel S, Zimmermann HW, Yagmur E, et al. Low serum transferrin correlates with acute-on-chronic organ failure and indicates short-term mortality in decompensated cirrhosis. Liver international : official journal of the International Association for the Study of the Liver. 2017;37(2):232-41. 38. Viveiros A, Finkenstedt A, Schaefer B, Mandorfer M, Scheiner B, Lehner K, et al. Transferrin as a predictor of survival in cirrhosis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2018;24(3):343-51. 39. Guillard M, Morava E, van Delft FL, Hague R, Korner C, Adamowicz M, et al. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II. Clinical chemistry. 2011;57(4):593-602.